Sec Form 13D Filing - Coffman Raymond Scott filing for CBDMD INC (YCBD) - 2021-02-24

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
 
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13D
 
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
 
cbdMD, Inc.
(Name of Issuer)
 
Common Stock
(Title of Class of Securities)
 
12482W101
(CUSIP Number)
 
Mr. Raymond Scott Coffman
c/o 8845 Red Oak Boulevard
Charlotte, NC 28217
(Name, address and telephone number of person
authorized to receive notices and communications)
 
February 19, 2021
(Date of event which requires filing of this statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is subject to this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. ☐
 
*     The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosure provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (“Act”) or other subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes.)
 
 
 
 
 
 
 
CUSIP No.12482W101
SCHEDULE 13D
Page 2 of 5 Pages
 
1
NAME OF REPORTING PERSONS
    Raymond Scott Coffman
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 (a) ☐
 (b) ☐
3
SEC USE ONLY
 
4
SOURCE OF FUNDS
 
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e) ☐
   WC
6
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
 
NUMBER OF
7
SOLE VOTING POWER
 
10,015,916 shares 
SHARES
BENEFICIALLY
8
SHARED VOTING POWER
 
0 shares 
OWNED BY
EACH
9
SOLE DISPOSITIVE POWER
 
12,888,104 shares 
REPORTING
PERSON WITH
10
SHARED DISPOSITIVE POWER
 
0 shares 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
12, 888,104 shares (1)
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES  ☐
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
24.4%
14
TYPE OF REPORTING PERSON
IN
 
(1)            
represents (a) outstanding shares of the Issuer’s common stock over which the Reporting Person has dispositive control, and (b) 93,334 shares of the Issuer’s common stock underlying vested stock options. See Item 5.
 
 
 
 
 
CUSIP No.12482W101
SCHEDULE 13D
Page 3 of 5 Pages
 
Item 1.    
Security and Issuer.
 
This Schedule 13D relates to the common stock, par value $0.001 per share, of cbdMD, Inc., a North Carolina corporation (the “Issuer”). The Issuer's principal executive offices are located at 8845 Red Oak Boulevard, Charlotte, NC 28217.
 
Item 2.      
Identity and Background.
 
The Reporting Person is Raymond Scott Coffman. The Reporting Person's business address is 8845 Red Oak Boulevard, Charlotte, NC 28217. The Reporting Person is a member of the Board of Directors, co-Chief Executive Officer and President of the Issuer.
 
During the past five years the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) nor was the Reporting Person a party to a civil proceeding or a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoying future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
 
The Reporting Person is a U.S. citizen.
 
Item 3.   
Source and Amount of Funds or Other Consideration.
 
Not applicable.
 
Item 4.       
Purpose of Transaction.
 
All of the Issuer’s securities owned by the Reporting Person were acquired for investment purposes only and are being held as a long-term investments. The Reporting Person does not have any current plans or proposals which relate to or would result in any matters set forth in Items 4(a) through 4(j) of Schedule 13D.
 
Item 5.            
Interest in Securities of the Issuer.
 
The number of outstanding shares of the Issuer's common stock beneficially owned by the Reporting Person includes:
 
●
3,684,000 shares held of record by Edge of Business, LLC (“Edge of Business”);
●
9,110,770 shares held of record by the Coffman Family Office, LLC (“Coffman Family Office”); and
●
93,334 shares underlying vested stock options with an exercise price of $3.15 per share.
 
The Reporting Person has sole voting and dispositive control over securities owned of record by Edge of Business. Coffman Management, LLC (“Coffman Management”) is the Manager of Coffman Family Office and the Reporting Person is the Manager of Coffman Management. Except as set forth in this Item 5, the Reporting Person has sole voting and dispositive control over securities owned of record by Coffman Family Office. The Reporting Person disclaims beneficial ownership of the securities held of record by each of these entities except to the extent of his pecuniary interest therein.
 
 
 
 
CUSIP No.12482W101
SCHEDULE 13D
Page 4 of 5 Pages
 
Of the 9,110,770 shares of common stock held of record by Coffman Family Office, the Reporting Person has the sole power to vote 6,238,582 shares. The balance of 2,872,188 shares are subject to the terms of a Voting Trust Agreement dated February 26, 2020 between the Issuer and the Family Office pursuant to which until such time as the unrestricted voting rights to these shares have vested, the voting rights to such shares are held by the independent chairman of the Audit Committee of the Issuer’s board of directors who will vote such shares on any matter brought before the Issuer’s shareholders in accordance with the recommendation of its Board of Directors. The voting rights to the 2,872,188 shares vest in equal parts on each of June 20, 2022 and December 20, 2023.
 
The number of outstanding shares of the Issuer’s common stock beneficially owned by the Reporting Person excludes:
 
●
46,666 shares of common stock underlying unvested stock options; and
●
Earnout Rights to up to an additional 6,645,230 shares of the Issuer’s common stock which are held of record by the Family Office.
 
On February 19, 2021 the Reporting Person sold 3,000 shares of the Issuer’s common stock at $4.2819 per share and on February 22, 2021 the Reporting Person sold an additional 122,000 shares of the Issuer’s common stock at $4.2525 per share. These shares were sold in same-day, same-way open market sales. Please see Form 4 filed by the Reporting Person with the SEC on February 23, 2021.
 
Item 6. 
Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.
 
The information appearing in Item 5 is incorporated by reference into this Item 6.
 
Item 7.   
Material to be Filed as Exhibits.
 
None.
 
 
 
 
 
CUSIP No.12482W101
SCHEDULE 13D
Page 5 of 5 Pages
 
 
SIGNATURES
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct.
 
 Date: February 24, 2021
/s/ Raymond Scott Coffman
 
Raymond Scott Coffman